| A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer (NCT05498428) | Janssen Research & Development, LLC | 2022-11-11 |
| A Study to Evaluate the Efficacy and Safety of ZM-H1505R in Combination With ETV Compared With ETV Monotherapy in Patients With CHB (NCT05484466) | Shanghai Zhimeng Biopharma, Inc. | 2022-11-11 |
| Gemeprost Versus Dinoprostone in First Trimester Miscarriages (NCT05342467) | National University of Malaysia | 2022-11-11 |
| A Study of RC108-ADC in Subjects With Advanced Digestive System Malignant Tumor (NCT05628857) | RemeGen Co., Ltd. | 2022-11-11 |
| Asciminib Monotherapy, With Dose Escalation, for 2nd and 1st Line Chronic Myelogenous Leukemia (NCT05384587) | Novartis Pharmaceuticals | 2022-11-11 |
| Personalized Risk-Adapted Therapy in Post-Pubertal Patients With Newly-Diagnosed Medulloblastoma (NCT04402073) | European Organisation for Research and Treatment of Cancer - EORTC | 2022-11-11 |
| Clinical Trial to Evaluate Safety and Efficacy of Cell Therapy in Patients With Cicatricial Conjuntivitis. (NCT05520086) | Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz | 2022-11-11 |
| Articaine Versus Lidocaine Buccal Infiltration (NCT05223075) | Fayoum University | 2022-11-11 |
| the Efficacy and Safety of Rulonilimab in Combination With Lenvatinib in Hepatocellular Carcinoma (NCT05408221) | Shandong New Time Pharmaceutical Co., LTD | 2022-11-11 |
| Pemigatinib After Curative Local Therapy in Advanced iCCA With FGFR2 Fusion/Rearrangements (NCT05565794) | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | 2022-11-11 |
| A Study of C-CAR088 in Patients With Relapsed or Refractory Multiple Myeloma (NCT05521802) | Shanghai AbelZeta Ltd. | 2022-11-11 |
| Phase 2/Phase 3 Study To Evaluate The Efficacy And Safety Of Ramatroban Along With The Standard Of Care In Subjects Hospitalized For COVID Pneumonia (NCT05706454) | KARE Biosciences | 2022-11-10 |
| Intranasal Versus Nebulized Midazolam in Behaviuor Modification of Preschool Children Undergoing Dental Treatment (NCT05883150) | Nourhan M.Aly | 2022-11-10 |
| Phase 2 Study of EDG-5506 in Becker Muscular Dystrophy (GRAND CANYON) (NCT05291091) | Edgewise Therapeutics, Inc. | 2022-11-10 |
| A Phase I/II Dose-escalating Study of the Safety, Tolerability and Efficacy of KIO-301 Administered Intravitreally to Patients With Retinitis Pigmentosa and Choroideremia (ABACUS) (NCT05282953) | Kiora Pharmaceuticals, Inc. | 2022-11-10 |
| A Pilot Study of Thermodox and MR-HIFU for Treatment of Relapsed Solid Tumors (NCT04791228) | Children's National Research Institute | 2022-11-10 |
| A Study to Evaluate EDP-235 in Non-hospitalized Adults With COVID-19 (NCT05616728) | Enanta Pharmaceuticals, Inc | 2022-11-10 |
| Cancer Preventive Vaccine Nous-209 for Lynch Syndrome Patients (NCT05078866) | National Cancer Institute (NCI) | 2022-11-10 |
| A Phase Ic/IIb Study to Evaluate the Efficacy，Safety and Pharmacokinetics of HST in Patients With CHB (NCT06122454) | Xi'an Xintong Pharmaceutical Research Co.,Ltd. | 2022-11-10 |
| To Assess the Efficacy of the Investigational Products Compared to Placebo in Participants With IPF (NCT05497284) | Novartis Pharmaceuticals | 2022-11-10 |
| HAIC Sequential TAE Combined With Lenvatinib and Tislelizumab in Unresectable HCC (NCT05532319) | Guangxi Medical University | 2022-11-10 |
| Avatrombopag Combined With IST as First-line Treatment for SAA (NCT05720234) | Institute of Hematology & Blood Diseases Hospital, China | 2022-11-10 |
| Phase II Randomised Controlled Trial of Patient-specific Adaptive vs. Continuous Abiraterone or eNZalutamide in mCRPC (NCT05393791) | Leiden University Medical Center | 2022-11-10 |
| Cannabis as a Complementary Treatment in Multiple Sclerosis (NCT05092191) | Centre hospitalier de l'Université de Montréal (CHUM) | 2022-11-10 |
| Safety, Tolerability and Pharmacodynamics of AZR-MD-001 in Contact Lens Discomfort (CLD) (NCT05548491) | Azura Ophthalmics | 2022-11-10 |
| Baricitinib in the Treatment of New-onset Juvenile Dermatomyositis (MYOCIT) (NCT05524311) | Assistance Publique - Hôpitaux de Paris | 2022-11-10 |
| Safety and Efficacy of FT14 Conditioning for Allogeneic HSCT in Acute Myeloid Leukemia (NCT07232953) | Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia | 2022-11-10 |
| A Proof-of-concept Study to Examine QUC398 in Participants With Knee OA (NCT05462990) | Novartis Pharmaceuticals | 2022-11-09 |
| Extension Study to Evaluate the Safety and Tolerability of NBI-921352 When Used With Anti-seizure Medications in Adults With Focal Onset Seizures (NCT05493293) | Neurocrine Biosciences | 2022-11-09 |
| Tolerability and Effectiveness of CGB-500 Topical Ointment, 1% Tofacitinib, for the Treatment of Atopic Dermatitis (NCT05487963) | CAGE Bio Inc. | 2022-11-09 |
| Olaparib for the Treatment of Castration Resistant Prostate Adenocarcinoma (NCT04951492) | University of Washington | 2022-11-09 |
| Almonertinib Therapy in Patients With Abnormal Liver Function After EGFR-TKI Treatment, or Almonertinib First-line Therapy in Patients With Basic Hepatopathy (NCT05662813) | West China Hospital | 2022-11-09 |
| A Trial of the Safety and Efficacy of SEP-363856 in the Treatment of Adults With Major Depressive Disorder (NCT05593029) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2022-11-09 |
| A Study of KL130008 in Adults With Severe Alopecia Areata (NCT05496426) | Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | 2022-11-09 |
| Ixekizumab Diabetes Intervention Trial (I-DIT) (NCT04589325) | Göteborg University | 2022-11-09 |
| Sintilimab Combined With Bevacizumab and Liver Protective Support Therapy in Unresectable Hepatocellular Carcinoma (NCT05616390) | Tianjin Medical University Cancer Institute and Hospital | 2022-11-09 |
| Study of AOC 1044 in Healthy Adult Volunteers and Participants With Duchenne Muscular Dystrophy (DMD) Mutations Amenable to Exon 44 Skipping (NCT05670730) | Avidity Biosciences, Inc. | 2022-11-09 |
| FLUOPANC-trial - Fluorescence-guided Surgery of Pancreatic and Bileduct Tumors Using cRGD-ZW800-1 (NCT05518071) | Leiden University Medical Center | 2022-11-09 |
| Phase II/III Study of the AVX/COVID-12 Vaccine Against COVID-19 Applied as a Booster. (NCT05710783) | Laboratorio Avi-Mex, S.A. de C.V. | 2022-11-09 |
| Radiodynamic Therapy (RDT) With Gliolan in Patients With First Recurrence of Brain Tumor (NCT05590689) | Universität Münster | 2022-11-09 |
| Testing an Omega-3 Fatty Acid-Based Anti-Cancer Therapy for Patients With Triple-Negative Inflammatory Breast Cancer That Has Spread to Other Parts of the Body (NCT05198843) | National Cancer Institute (NCI) | 2022-11-08 |
| Paxlovid for Treatment of Long Covid (NCT05576662) | Stanford University | 2022-11-08 |
| Cardiac MRI-guided Deferiprone Therapy for Acute Myocardial Infarction Patients (NCT05604131) | Rohan Dharmakumar | 2022-11-08 |
| An Efficacy, Safety, Tolerability and Dose Finding Study of XXB750 in Resistant Hypertension Patients. (NCT05562934) | Novartis Pharmaceuticals | 2022-11-08 |
| Transcranial Magnetic Stimulation in Smokers: an Examination of Mediating Neural Pathways. (NCT05651334) | Kent State University | 2022-11-08 |
| Study of Purinostat Mesylate for Injection in the Treatment of Relapsed or Refractory Diffuse Large B-cell Lymphoma (R/R DLBCL) (NCT05563844) | Chengdu Zenitar Biomedical Technology Co., Ltd | 2022-11-08 |
| A Study to Evaluate Efficacy and Safety of Deucravacitinib in Participants With Alopecia Areata (NCT05556265) | Bristol-Myers Squibb | 2022-11-08 |
| Evaluating the Efficacy and Safety of QL0911 in the Prevention of Chemotherapy- Induced Thrombocytopenia (NCT05554913) | Qilu Pharmaceutical Co., Ltd. | 2022-11-08 |
| A Study of Safety and Efficacy of Sirolimus for Injection (Albumin-bound) in Patients With Advanced Malignant Perivascular Epithelioid Cell Tumor (PEComa) (NCT05625919) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2022-11-08 |
| First-in-human Study Aiming to Characterize the Safety, Tolerability, Pharmacokinetic and Preliminary Signs of Activity of ABD-3001 in Refractory or Relapsed AML and High Risk MDS Adult Patients (NCT05601726) | Advanced BioDesign | 2022-11-08 |
| High vs. Standard Dose Influenza Vaccine in Lung Allograft Recipients (NCT05215327) | Vanderbilt University Medical Center | 2022-11-08 |
| Phase II Study of Hemay005 in Patients With Active Ulcerative Colitis (NCT05486104) | Ganzhou Hemay Pharmaceutical Co., Ltd | 2022-11-08 |
| Efficacy and Safety of Houtou Jianweiling Tablet in the Treatment of Chronic Non-Atrophic Gastritis (NCT04672018) | University of Karachi | 2022-11-08 |
| Tiragolumab Plus Atezolizumab Versus Atezolizumab in the Treatment of Stage II Melanoma Patients Who Are ctDNA-positive Following Resection (NCT05060003) | Washington University School of Medicine | 2022-11-08 |
| Glucosamine Sulphate Versus Ginger in Non-Surgical Periodontal Therapy (NCT06200415) | Ain Shams University | 2022-11-08 |
| Extension Study to Provide Continued Treatment for Patients With Hematologic Malignancies Previously Enrolled in Studies With Tafasitamab (NCT06465433) | Incyte Corporation | 2022-11-08 |
| Open-label, Long-term Safety Study of LP352 in Subjects With Developmental and Epileptic Encephalopathy (NCT05626634) | Longboard Pharmaceuticals | 2022-11-08 |
| Clinical and Radiographic Evaluation of Natural Bovine Bone With Hyaluronic Acid on Osseointegration of Immediate Implant. (NCT07199725) | Suez Canal University | 2022-11-08 |
| A Trial of a Peptide-based Group A Streptococcal (GAS) Vaccine Candidate in Healthy Individuals. (NCT04882514) | University of Alberta | 2022-11-07 |
| Mandibular Advancement vs Home Treatment for Primary Snoring (NCT05756647) | Washington University School of Medicine | 2022-11-07 |
| A Study of mRNA-1647 Cytomegalovirus Vaccine in Healthy Participants 9 to 15 Years of Age and Participants 16 to 25 Years of Age (NCT05575492) | ModernaTX, Inc. | 2022-11-07 |
| Midodrine Effect on the Mortality Rates in Septic Shock Patients (NCT05778838) | Noha Mansour | 2022-11-07 |
| A Study of Tebapivat (AG-946) in Participants With Anemia Due to Lower-Risk Myelodysplastic Syndromes (LR-MDS) (NCT05490446) | Agios Pharmaceuticals, Inc. | 2022-11-07 |
| Safety and Efficacy of Cyclophosphamide, Sorafenib, Bevacizumab, and Atezolizumab in Pediatric Solid Tumor Patients (NCT05468359) | St. Jude Children's Research Hospital | 2022-11-07 |
| Study of Neoadjuvant Olaparib Monotherapy and Olaparib and Durvalumab Combination in HER2 Negative BRCAm Breast Cancer (NCT05498155) | AstraZeneca | 2022-11-07 |
| Study of Pembrolizumab, Lenvatinib and Chemotherapy Combination in First Line Extensive-stage Small Cell Lung Cancer (NCT05384015) | Fundación GECP | 2022-11-07 |
| Pamiparib Combined With Surufatinib for the Neoadjuvant Treatment of Unresectable Ovarian Cancer (NCT05652283) | Bai-Rong Xia | 2022-11-06 |
| An Open-label Extension Trial of HZNP-HZN-825-301 in Adult Participants With Diffuse Cutaneous Systemic Sclerosis (Diffuse Cutaneous SSc) (NCT05626751) | Amgen | 2022-11-04 |
| Varenicline for Treatment of E-cigarette Dependence (NCT05541497) | Yale University | 2022-11-04 |
| Study of Bavituximab, Axitinib, and Avelumab in Advanced Hepatocellular Carcinoma (NCT05249569) | University of Texas Southwestern Medical Center | 2022-11-04 |
| Safety of Cenobamate in Japanese Subjects With Partial Onset Seizures (NCT06590896) | Ono Pharmaceutical Co., Ltd. | 2022-11-04 |
| A Study to Give Treatment Inside the Eye to Treat Retinoblastoma (NCT05504291) | Children's Oncology Group | 2022-11-04 |
| Enhancing the Natriuretic Peptide System in HFpEF (NCT05279742) | Horng Chen | 2022-11-04 |
| A Study to Evaluate the Safety and Efficacy of 2ccPA in Patients With Symptomatic Knee Osteoarthritis (NCT05807529) | Orient Europharma Co., Ltd. | 2022-11-03 |
| Nivolumab Combined With SOX Used in the Perioperative Treatment (NCT05739045) | Xiangdong Cheng | 2022-11-03 |
| Contrast-Enhanced Ultrasound Imaging for Diagnosing Recurrent Renal Cell Carcinoma (RCC) Post Ablation (NCT05641935) | john eisenbrey | 2022-11-03 |
| Study on Two Adjuvanted Dose Levels of Panblok H7+MF59 Compared for Immunogenicity and Safety With an Unadjuvanted Dose of Panblok H7 in Participants 18 Years of Age and Older (NCT05608005) | Sanofi Pasteur, a Sanofi Company | 2022-11-03 |
| Heat Therapy, Functional Capacity, and Vascular Health in Older Adults (NCT05706181) | University of North Texas Health Science Center | 2022-11-03 |
| Efficacy and Safety of Luspatercept for the Treatment of Anemia Due to MDS With del5q, Refractory/Resistant/Intolerant to Prior Treatments, RBC-TD (NCT05924100) | Associazione Qol-one | 2022-11-03 |
| Smoking Cessation Pharmacotherapy-Nurse Practitioner Led Tobacco Treatment Team Study (NCT05733767) | Baystate Medical Center | 2022-11-03 |
| A Clinical Study to Investigate the Efficacy of Tigilanol Tiglate Directly in Head and Neck Cancer (NCT05608876) | QBiotics Group Limited | 2022-11-03 |
| Safety and Efficacy Evaluation of BRL-101 in Subjects With Transfusion-Dependent β-Thalassemia (NCT05577312) | Bioray Laboratories | 2022-11-02 |
| Chemoradiotherapy Following Immunotherapy Plus Chemotherapy for Locally-advanced Esophageal Squamous Cell Cancer (RICE) (NCT05621707) | Shanghai Chest Hospital | 2022-11-02 |
| Tetracycline Treatment Tolerability Trial (NCT05219929) | Johns Hopkins University | 2022-11-02 |
| A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1010 in Healthy Adults (NCT05606965) | ModernaTX, Inc. | 2022-11-02 |
| Combination Therapy of HAIC, Sintilimab and Bevacizumab for Advanced Hepatocellular Carcinoma (NCT05617430) | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 2022-11-02 |
| Home Transcutaneous Electrical Acustimulation (TEA) (NCT05519683) | University of Michigan | 2022-11-02 |
| Respiratory Syncytial Virus (RSV) Human Challenge Study of Molnupiravir in Healthy Participants (MK-4482-017) (NCT05559905) | Merck Sharp & Dohme LLC | 2022-11-02 |
| Extension Study of Pimavanserin in Irritability Associated With Autism Spectrum Disorder (NCT05555615) | ACADIA Pharmaceuticals Inc. | 2022-11-02 |
| Phase 2 Study for the Patient, Who Has Diagnosed With Small Cell Lung Cancer (SCLC) or Non Small Cell Lung Cancer (NSCLC) or Renal Cell Carcinoma (RCC) and Finished the First Line Stand Treatment , Need More Treatment (NCT05363280) | Advenchen Pharmaceuticals, LLC. | 2022-11-01 |
| Obinutuzumab in Combination With Lenalidomide in Relapsed or Refractory Marginal Zone Lymphoma (NCT05846750) | Institute of Hematology & Blood Diseases Hospital, China | 2022-11-01 |
| Study Evaluating UCART20x22 in B-Cell Non-Hodgkin Lymphoma (NCT05607420) | Cellectis S.A. | 2022-11-01 |
| Interleaved TMS-fMRI for Hippocampal Stimulation: Modeling Dose-Response Relationship in Amnestic Mild Cognitive Impairment (NCT05515952) | University of Arizona | 2022-11-01 |
| Study of Camrelizumab Plus Apatinib and Chemotherapy as Neoadjuvant Therapy in Participants With Triple Negative Breast Cancer (TNBC) (NCT05447702) | West China Hospital | 2022-11-01 |
| Fudan University Shanghai Cancer Center Breast Cancer Precision Platform Series Study- Neoadjuvant Therapy (NCT05582499) | Fudan University | 2022-11-01 |
| KAT-101 in Subjects With Hepatocellular Carcinoma (HCC) (NCT05603572) | Primocure Pharma | 2022-11-01 |
| Study of Donafenib Combined With Tislelizumab in the Adjuvant Treatment of Primary HCC With High Risk of Recurrence (NCT05545124) | Henan Cancer Hospital | 2022-11-01 |
| Camrelizumab Plus Anlotinib in Patients With Recurrent Sporadic MMRd Endometrial Cancer (NCT05550558) | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2022-11-01 |
| Relationship Between Serum Vitamin D and Outcomes of Liver Transplantation in Cirrhotic Patients Undergoing Liver Transplantation and Effects of Vitamin D Supplementation in Post-transplant Period (NCT05568836) | National Nutrition and Food Technology Institute | 2022-11-01 |
| Medroxyprogesterone Acetate vs LNG-IUS in Early-stage Endometrioid Carcinoma and Atypical Hyperplasia Patients (NCT05565573) | Hua Li | 2022-11-01 |